Yes. The last one I executed on was to do in depth fundamental analysis on all the ASX listed biotech/pharma companies (there are about 70 of them). Out of this process I found one very undervalued company that I took a large strategic investment in and joined the board to help turn it around. This has turned into a very good investment, although it has taken up a lot of my time.